Nova Patents
AT411032T

Uses of chitosan oligosaccharides

Abstract

Composition chitosan oligomer for preventing or treating inflammation or hypersensitivity in a human or an animal, said composition being for oral, intradermal, intravenous, intranasal, subcutaneous or topical administration and obtaining said chitosan oligomer from deacetylated chitin at least 75% and having a molecular weight less than 2000 Da.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

13 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
2364924CanadaA

Members13

Family members, oldest first
DocumentOfficeKind
CA2507846A1CanadaA1
WO03051376A1World Intellectual Property Organization (WIPO)A1
AU2002351583A1AustraliaA1
EP1455802A1European Patent Office (EPO)A1
US2005004057A1United States of AmericaA1
US2007167400A1United States of AmericaA1
AT411032TThis recordAustriaT
EP1455802B1European Patent Office (EPO)B1
PT1455802EPortugalE
DE60229431D1GermanyD1
DK1455802T3DenmarkT3
ES2315417T3SpainT3
SI1455802T1SloveniaT1